Inventor · disambiguated record
Gerald Mcmahon
Also filed as: MCMAHON GERALD · MCMAHON GERALD M
73 granted patents·12 pending applications·4,924 citations·filing 1995–2024
99Inventor score
Files withSUGEN INC70CELLDEX THERAPEUTICS INC3ASTA MEDICA AG2YISSUM RES DEV CO2KOLLTAN PHARMACEUTICALS INC1
Top patents by PatentIndex Score
85 records- 0198US6506763B23-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activitySUGEN INC·Filed 2001·Granted Jan 14, 2003·76 cites·22 claims
- 0298US6133305A3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activitySUGEN INC·Filed 1998·Granted Oct 17, 2000·125 cites·27 claims
- 0398US5886020A3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of diseaseSUGEN INC·Filed 1996·Granted Mar 23, 1999·376 cites·45 claims
- 0498US5883113A3-(4'-Bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of diseaseSUGEN INC·Filed 1996·Granted Mar 16, 1999·373 cites·27 claims
- 0598US5834504A3-(2'-halobenzylidenyl)-2-indolinone compounds for the treatment of diseaseSUGEN INC·Filed 1996·Granted Nov 10, 1998·358 cites·24 claims
- 0698US5792783A3-heteroaryl-2-indolinone compounds for the treatment of diseaseSUGEN INC·Filed 1996·Granted Aug 11, 1998·589 cites·28 claims
- 0798US5712395ACompounds for the treatment of disorders related to vasculogenesis and/or angiogenesisYISSUM RES DEV CO·Filed 1995·Granted Jan 27, 1998·118 cites·1 claims
- 0897US6239161B1Method and compositions for inhibition of adaptor protein/tyrosine kinase interactionsSUGEN INC·Filed 2000·Granted May 29, 2001·54 cites·9 claims
- 0997US5883116A3-(2'-alkoxybenzylidenyl)-2-indolinone and analogues thereof for the treatment of diseaseSUGEN INC·Filed 1996·Granted Mar 16, 1999·180 cites·26 claims
- 1097US5773459AUrea- and thiourea-type compoundsSUGEN INC·Filed 1995·Granted Jun 30, 1998·117 cites·18 claims
- 1197US5763441ACompounds for the treatment of disorders related to vasculogenesis and/or angiogenesisSUGEN INC·Filed 1995·Granted Jun 9, 1998·111 cites·4 claims
- 1297US5650415AQuinoline compoundsSUGEN INC·Filed 1995·Granted Jul 22, 1997·235 cites·14 claims
- 1396US6683082B2Bicyclic protein kinase inhibitorsSUGEN INC·Filed 2001·Granted Jan 27, 2004·60 cites·34 claims
- 1496US5891917ACertain acrylonitrile-sulfonamide derivativesSUGEN INC·Filed 1997·Granted Apr 6, 1999·75 cites·16 claims
- 1595US5935993ATyrphostin like compoundsSUGEN INC·Filed 1997·Granted Aug 10, 1999·72 cites·16 claims
- 1695US5880141ABenzylidene-Z-indoline compounds for the treatment of diseaseSUGEN INC·Filed 1995·Granted Mar 9, 1999·106 cites·7 claims
- 1795US5792771AQuinazoline compounds and compositions thereof for the treatment of diseaseSUGEN INC·Filed 1995·Granted Aug 11, 1998·155 cites·12 claims
- 1894US7211600B2Methods of modulating c-kit tyrosine protein kinase function with indolinone compoundsSUGEN INC·Filed 2005·Granted May 1, 2007·49 cites·4 claims
- 1994US6610688B24-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitorsSUGEN INC·Filed 2000·Granted Aug 26, 2003·74 cites·22 claims
- 2093US6316635B12-indolinone derivatives as modulators of protein kinase activitySUGEN INC·Filed 1999·Granted Nov 13, 2001·87 cites·29 claims
- 2193US6225346B1Tyrphostin like compoundsSUGEN INC·Filed 1999·Granted May 1, 2001·61 cites·9 claims
- 2292US6855723B2Methods of modulating serine/threonine protein kinase function with azabenzimidazole-based compoundsZENTARIS GMBH·Filed 2002·Granted Feb 15, 2005·53 cites·3 claims
- 2392US6103728AQuinazolinesSUGEN INC·Filed 1997·Granted Aug 15, 2000·58 cites·11 claims
- 2492US5602171AMethods of inhibiting phosphatase activity and treatment of disorders associated therewith using naphthopyrones and derivatives thereofSUGEN INC·Filed 1995·Granted Feb 11, 1997·54 cites·12 claims
- 2591US6143765APharmaceutical compositions and methods for modulating signal transductionSUGEN INC·Filed 1998·Granted Nov 7, 2000·44 cites·22 claims
- 2690US6696448B23-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitorsSUGEN INC·Filed 2002·Granted Feb 24, 2004·65 cites·4 claims
- 2790US6689806B1Indolinone compounds as kinase inhibitorsSUGEN INC·Filed 2000·Granted Feb 10, 2004·29 cites·19 claims
- 2890US6395734B1Pyrrole substituted 2-indolinone protein kinase inhibitorsSUGEN INC·Filed 1999·Granted May 28, 2002·79 cites·23 claims
- 2989US6911446B2Methods of modulating serine/threonine protein kinase function with quinazoline-based compoundsSUGEN INC·Filed 2001·Granted Jun 28, 2005·37 cites·17 claims
- 3089US6147106AIndolinone combinatorial libraries and related products and methods for the treatment of diseaseSUGEN INC·Filed 1997·Granted Nov 14, 2000·37 cites·15 claims
- 3188US6596772B1Phosphate mimics and methods of treatment using phosphatase inhibitorsSUGEN INC·Filed 2000·Granted Jul 22, 2003·53 cites·20 claims
- 3288US6093728AMethods of modulating serine/threonine protein kinase function with azabenzimidazole-based compoundsASTA MEDICA AG·Filed 1998·Granted Jul 25, 2000·72 cites·11 claims
- 3388US5981569ASubstituted phenylacrylonitrile compounds and compositions thereof for the treatment of diseaseYISSUM RES DEV CO·Filed 1995·Granted Nov 9, 1999·86 cites·16 claims
- 3488US5883110APharmaceutical compositions and methods for modulating signal transductionSUGEN INC·Filed 1996·Granted Mar 16, 1999·31 cites·22 claims
- 3588US5849742ACompounds for the treament of disorders related to vasculogenesis and/or angiogenesisSUGEN INC·Filed 1997·Granted Dec 15, 1998·28 cites·14 claims
- 3688US5614642AMethods of inhibiting phosphatase activity and treatment of disorders associated therewith using naphthopyrones and derivatives thereofSUGEN INC·Filed 1996·Granted Mar 25, 1997·35 cites·4 claims
- 3787US10239943B2Treatment of eosinophil or mast cell related disordersKOLLTAN PHARMACEUTICALS INC·Filed 2015·Granted Mar 26, 2019·6 cites·6 claims
- 3887US5886195AThienyl compounds for inhibition of cell proliferative disordersSUGEN INC·Filed 1997·Granted Mar 23, 1999·34 cites·28 claims
- 3987US5710173AThienyl compounds for inhibition of cell proliferative disordersSUGEN INC·Filed 1995·Granted Jan 20, 1998·34 cites·24 claims
- 4086US10774146B2Treatment of eosinophil or mast cell related disordersCELLDEX THERAPEUTICS INC·Filed 2019·Granted Sep 15, 2020·2 cites·7 claims
- 4185US6660763B2Bis-indolylquinone compoundsSUGEN INC·Filed 2000·Granted Dec 9, 2003·20 cites·4 claims
- 4285US6004967APsoriasis treatment with quinazoline compoundsSUGEN INC·Filed 1997·Granted Dec 21, 1999·74 cites·8 claims
- 4385US5780496AMethod and compositions for inhibition of adaptor protein/tyrosine kinase interactionsSUGEN INC·Filed 1996·Granted Jul 14, 1998·24 cites·27 claims
- 4484US7119090B2Pyrrole substituted 2-indolinone protein kinase inhibitorsSUGEN INC·Filed 2002·Granted Oct 10, 2006·18 cites·10 claims
- 4584US6329375B1Tricyclic quinoxaline derivatives as protein tyrosine kinase inhibitorsSUGEN INC·Filed 1998·Granted Dec 11, 2001·27 cites·16 claims
- 4684US6204267B1Methods of modulating serine/thereonine protein kinase function with quinazoline-based compoundsSUGEN INC·Filed 1998·Granted Mar 20, 2001·61 cites·18 claims
- 4784US6114371A3-(cyclohexanoheteroarylidenyl)-2-indolinone protein tyrosine kinase inhibitorsSUGEN INC·Filed 1998·Granted Sep 5, 2000·38 cites·25 claims
- 4884US2024287180A1Treatment of eosinophil or mast cell related disordersCELLDEX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4983US6486185B13-heteroarylidene-2-indolinone protein kinase inhibitorsSUGEN INC·Filed 1998·Granted Nov 26, 2002·64 cites·52 claims
- 5083US5763470ABenzopyran compounds and methods for their useSUGEN INC·Filed 1995·Granted Jun 9, 1998·57 cites·8 claims
Showing the top 50 of 85 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →